Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...

Attention Deficit Hyperactivity Disorder (ADHD) and cervical cancer are now covered under the National Health Fund’s (NHF) ...

The National Health Fund (NHF) has announced that effective March 27, 2025, attention deficit hyperactivity disorder (ADHD) and cervical cancer are covered on the NHF's Card Programme, bringing the ...

The company developed, commercialized and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.

StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note released on Friday. The firm issued a sell rating on the specialty pharmaceutical company’s stock.

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

Wall Street is suffering from volatility in the first quarter of 2025. Out of the three large-cap indexes, the S&P 500 and ...

Learn how it's used in combination with other medications in emergency department migraine cocktails and home treatments.

There’s also the option of medication or diet and lifestyle changes to stimulate the stomach muscles like metoclopramide (Reglan) and erythromycin (Eryc). If the condition doesn’t improve with ...

plus daily doses of acetaminophen and an anti-nausea drug called metoclopramide. Carol felt uneasy using the medications. Like many Americans and an even greater proportion of Europeans, Carol (who ...